Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio

Stocks Yahoo Finance By Yahoo Finance 25 May 2026 19:54 1 min read

Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio

Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio

Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio

Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.